Product Information
SULINDAC 150 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1953 per EA under NDC 00591566101. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591566101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SULINDACApproval Type
Generic (ANDA)
FDA Application
ANDA071891On Market Since
4/3/1990
Pharmacological Classes
Price Statistics
The NADAC for SULINDAC 150 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 55.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1953 per EA |
|---|---|
| All-time high | $0.1969 (Jun 10, 2026) |
| All-time low | $0.1256 (Nov 28, 2013) |
| 52-week high | $0.1969 |
| 52-week low | $0.1784 |
| Median price | $0.1558 |
| Average price | $0.1599 |
| Largest weekly change | -27.0% (Apr 17, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SULINDAC 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULINDAC 150 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1953 per EA (NDC 00591566101), effective Jun 24, 2026.
How has the price of SULINDAC 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULINDAC 150 MG TABLET has risen 55.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SULINDAC 150 MG TABLET?
Since Nov 28, 2013, the NADAC for SULINDAC 150 MG TABLET has ranged from a low of $0.1256 (Nov 28, 2013) to a high of $0.1969 (Jun 10, 2026), with a median of $0.1558 per EA.
Are there cheaper alternatives to SULINDAC 150 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SULINDAC 150 MG TABLET, but none are currently priced below it.
Who manufactures SULINDAC 150 MG TABLET?
SULINDAC 150 MG TABLET (NDC 00591566101) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification